2 completed, 1 terminated, 1 withdrawn. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Hyperplasia: new trials by email Literature Review of Hyperplasia trials Research Report on Hyperplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia Subcutaneous hydrocortisone - Congenital Adrenal Hyperplasia, Hyperplasia | Phase 1 | Completed | University of Minnesota | 11 | 2019-01-01 | 2025-06-25 |
| Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia NBI-77860 - Congenital Adrenal Hyperplasia | Phase 1 | Withdrawn | Neurocrine Biosciences | 2015-02-01 | 2015-06-11 | |
| Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1 PET/CT, Laboratory Testing, Safety Testing - Breast Cancer, Head and Neck Cancer | Phase 1 | Completed | Washington University School of Medicine | 31 | 2009-01-01 | 2014-12-09 |
| Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis edifoligide (E2F Decoy) - Hyperplasia, Chronic Renal Failure | Phase 1 / Phase 2 | Terminated | Anesiva, Inc. | 2004-05-01 | 2005-07-19 |
Adrenal Gland Diseases (2) · Adrenal Hyperplasia, Congenital (2) · Adrenocortical Hyperfunction (2) · Disorders of Sex Development (2) · Genetic Diseases, Inborn (2) · Steroid Metabolism, Inborn Errors (2) · Urogenital Abnormalities (2) · Adrenogenital Syndrome (1) · Breast Neoplasms (1) · Congenital Abnormalities (1) · Congenital adrenal hyperplasia due to 21 hydroxylase deficiency (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine System Diseases (1) · Gonadal Disorders (1)
Pathological Conditions, Signs and Symptoms (4) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Male Urogenital Diseases (3) · Pathologic Processes (3) · Urogenital Diseases (3) · Nutritional and Metabolic Diseases (2) · Adrenogenital Syndrome (1) · Breast Diseases (1) · Chronic Disease (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Disease Attributes (1) · Endocrine System Diseases (1) · Gonadal Disorders (1)
NBI 77860 (1) · edifoligide (1)
Anesiva, Inc. (1) · Neurocrine Biosciences (1) · University of Minnesota (1) · Washington University School of Medicine (1)
United States (4)
Farrokh Dehdashti, M.D. (1) · Kyriaki Sarafoglou, MD (1)